Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 Dec;80(12):1111. doi: 10.1136/bjo.80.12.1111

Retinal arterial occlusion associated with resistance to activated protein C.

S Vignes, B Wechsler, C Elmaleh, N Cassoux, M H Horellou, P Godeau
PMCID: PMC505715  PMID: 9059282

Full text

PDF

Page 1111

1111

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown G. C., Magargal L. E., Shields J. A., Goldberg R. E., Walsh P. N. Retinal arterial obstruction in children and young adults. Ophthalmology. 1981 Jan;88(1):18–25. doi: 10.1016/s0161-6420(81)35080-5. [DOI] [PubMed] [Google Scholar]
  2. Dahlbäck B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism. J Clin Invest. 1994 Sep;94(3):923–927. doi: 10.1172/JCI117458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dhôte R., Bachmeyer C., Horellou M. H., Toulon P., Christoforov B. Central retinal vein thrombosis associated with resistance to activated protein C. Am J Ophthalmol. 1995 Sep;120(3):388–389. doi: 10.1016/s0002-9394(14)72170-1. [DOI] [PubMed] [Google Scholar]
  4. Greven C. M., Slusher M. M., Weaver R. G. Retinal arterial occlusions in young adults. Am J Ophthalmol. 1995 Dec;120(6):776–783. doi: 10.1016/s0002-9394(14)72731-x. [DOI] [PubMed] [Google Scholar]
  5. Greven C. M., Weaver R. G., Owen J., Slusher M. M. Protein S deficiency and bilateral branch retinal artery occlusion. Ophthalmology. 1991 Jan;98(1):33–34. doi: 10.1016/s0161-6420(91)32355-8. [DOI] [PubMed] [Google Scholar]
  6. Israels S. J., Seshia S. S. Childhood stroke associated with protein C or S deficiency. J Pediatr. 1987 Oct;111(4):562–564. doi: 10.1016/s0022-3476(87)80122-1. [DOI] [PubMed] [Google Scholar]
  7. Love P. E., Santoro S. A. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med. 1990 May 1;112(9):682–698. doi: 10.7326/0003-4819-112-9-682. [DOI] [PubMed] [Google Scholar]
  8. Simioni P., de Ronde H., Prandoni P., Saladini M., Bertina R. M., Girolami A. Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. Stroke. 1995 May;26(5):885–890. doi: 10.1161/01.str.26.5.885. [DOI] [PubMed] [Google Scholar]
  9. Svensson P. J., Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med. 1994 Feb 24;330(8):517–522. doi: 10.1056/NEJM199402243300801. [DOI] [PubMed] [Google Scholar]
  10. Zöller B., Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet. 1994 Jun 18;343(8912):1536–1538. doi: 10.1016/s0140-6736(94)92940-8. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES